Health Care: Drugs

Celgene Corporation (CELG: NASDAQ)

$123.64 0.20 | 0.16%
05/23/13 - 04:00 PM ET
Company Income Statement
Dec 2012 Dec 2011 Dec 2010 Dec 2009
Sales 5.51B 4.84B 3.63B 2.69B
Cost of Sales 210.18M 352.23M 250.66M 173.62M
Gross Operating Profit 5.30B 4.49B 3.38B 2.52B
Selling, General, and Administrative Expenses 1.37B 1.23B 950.63M 753.83M
Research & Development 1.72B 1.60B 1.13B 794.85M
Operating Income before D & A (EBITDA) 2.20B 1.66B 1.30B 967.59M
Depreciation & Amortization 283.45M 362.85M 259.09M 126.07M
Interest Income 15.26M 25.86M 44.76M 76.78M
Other Income - Net -17.01M -3.55M -11.08M 60.46M
Special Income / Charges -168.95M 284.69M 0.00 0.00
Total Income Before Interest Expenses (EBIT) 1.74B 1.46B 1.03B 977.67M
Interest Expense 63.20M 42.74M 12.63M 1.97M
Pre-Tax Income 1.68B 1.42B 1.01B 975.70M
Income Taxes 225.31M 102.07M 132.42M 198.96M
Minority Interest 0.00 -694.00K -320.00K 0.00
Net Income From Continuing Operations 1.46B 1.32B 880.51M 776.75M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 1.46B 1.32B 880.51M 776.75M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 1.46B 1.32B 880.51M 776.75M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 1.63B 1.18B 927.74M 776.75M
Preferred Dividends
Net Income Available To Common 1.46B 1.32B 880.51M 776.75M
Basic EPS from Continuing Ops. 3.38 2.89 1.90 1.69
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 3.38 2.89 1.90 1.69
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 3.38 2.89 1.90 1.69
Basic Normalized Net Income/Share 3.77 2.58 2.00 1.69
EPS fr Continuing Ops. 3.30 2.85 1.88 1.66
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 3.30 2.85 1.88 1.66
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 3.30 2.85 1.88 1.66
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 3.68 2.54 1.98 1.66
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with CELG

View All

Latest CELG Headlines from TheStreet

More Financial News for CELG

Press Releases for CELG

See All Press Releases

Partner Headlines for CELG

brokerage partners
watch thestreet tv
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter